Home  >  Products  >  B4GALNT1 (beta-1,4-N-acetyl-galactosaminyl transferase 1) Blocking Peptide (the middle region of B4GALNT1)(100ug)
B4GALNT1 (beta-1,4-N-acetyl-galactosaminyl transferase 1) Blocking Peptide (the middle region of B4GALNT1)(100ug)

B4GALNT1 (beta-1,4-N-acetyl-galactosaminyl transferase 1) Blocking Peptide (the middle region of B4GALNT1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-B4GALNT1 Antibody(ARP45118_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP45118
Size: 100ug
Weight: 59kDa
Gene: 2583
Format: Lyophilized powder
Target: GM2 and GD2 gangliosides are sialic acid-containing glycosphingolipids. GalNAc-T is the enzyme involved in the biosynthesis of G(M2) and G(D2) glycosphingolipids. B4GALNT1(GalNAc-T) catalyzes the transfer of GalNAc into G(M3) and G(D3) by a beta-1,4 linkage, resulting in the synthesis of G(M2) and G(D2), respectively.
Alternative names: GALGT; GALNACT
See Full Product Listings >